S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial
TED-A9 is high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs)…